MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 244 filers reported holding MYRIAD GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $436,000 | -13.1% | 16,300 | +7.8% | 0.02% | -14.3% |
| Q1 2019 | $502,000 | +42.6% | 15,120 | +22.9% | 0.02% | +31.2% |
| Q4 2018 | $352,000 | +153.2% | 12,300 | +310.0% | 0.02% | +220.0% |
| Q3 2018 | $139,000 | -10.9% | 3,000 | -28.5% | 0.01% | -28.6% |
| Q2 2018 | $156,000 | +75.3% | 4,193 | +39.8% | 0.01% | +75.0% |
| Q1 2018 | $89,000 | -14.4% | 3,000 | 0.0% | 0.00% | -42.9% |
| Q4 2017 | $104,000 | -4.6% | 3,000 | 0.0% | 0.01% | -12.5% |
| Q3 2017 | $109,000 | +41.6% | 3,000 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $77,000 | +35.1% | 3,000 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $57,000 | +14.0% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $50,000 | -95.3% | 3,000 | -94.1% | 0.01% | -94.5% |
| Q3 2016 | $1,054,000 | – | 50,934 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,646,330 | $75,731,000 | 4.08% |
| Tieton Capital Management, LLC | 91,948 | $4,230,000 | 3.37% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 369,355 | $16,990,000 | 1.54% |
| S&T BANK/PA | 165,071 | $7,594,000 | 1.42% |
| Millrace Asset Group, Inc. | 38,972 | $1,793,000 | 1.40% |
| Taylor Frigon Capital Management LLC | 39,929 | $1,836,000 | 1.39% |
| Summit Street Capital Management, LLC | 30,097 | $1,384,000 | 1.35% |
| AIMZ Investment Advisors, LLC | 43,485 | $2,000,000 | 1.29% |
| Matarin Capital Management, LLC | 413,193 | $19,006,878,000 | 1.22% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,357,351 | $62,438,000 | 1.05% |